Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YJ001 Spray in Diabetic Peripheral Neuropathic Pain
CTR20210079Phase 2Completed
- Sponsor
- Zhejiang Yuejia Pharmaceutical
- Start
- Jan 2021
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of YJ001 in diabetic polyneuropathy (DPN), sponsored by Zhejiang Yuejia Pharmaceutical. Started Jan 2021; status: completed.
02
Drugs
YJ001
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20210079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210079.